SysteMHC v.231201
Home Datasets Download Help About Update

Showing details for project SYSMHC00010



SampleIDNumReplicatesOrganismTissueTypeCellTypeMHCAllele
SampleID
NumReplicates
Organism
TissueType
CellType
MHCAllele
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_C_Subject_08 3 Human HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_CELG_Subject_11 3 Human HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_J_Subject_09 6 Human HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_MA_Subject_03 3 Human HLA-A02_01,HLA-A29_02,HLA-B57_01,HLA-B44_03,HLA-C07_01,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_PF1_Subject_04 3 Human HLA-A02_01,HLA-A01_01,HLA-B07_02,HLA-B44_03,HLA-C07_02,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_RT_Subject_10 3 Human HLA-A02_01,HLA-A01_01,HLA-B18_01,HLA-B39_24,HLA-C05_01,HLA-C07_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_PF1_Subject_04 1 Human HLA-A02_01,HLA-A01_01,HLA-B07_02,HLA-B44_03,HLA-C07_02,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_RT_Subject_10 1 Human HLA-A02_01,HLA-A01_01,HLA-B18_01,HLA-B39_24,HLA-C05_01,HLA-C07_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_01 3 Human HLA-A03_01,HLA-A29_02,HLA-B08_01,HLA-B44_03,HLA-C07_01,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_02 3 Human HLA-A03_01,HLA-A29_02,HLA-B08_01,HLA-B44_03,HLA-C07_01,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 15 Human HLA-A02_01,HLA-A29_02,HLA-B57_01,HLA-B44_03,HLA-C07_01,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 19 Human HLA-A02_01,HLA-A01_01,HLA-B07_02,HLA-B44_03,HLA-C07_02,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_05 7 Human HLA-A03_01,HLA-A11_01,HLA-B44_03,HLA-B50_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_06 6 Human HLA-A02_01,HLA-A11_01,HLA-B40_01,HLA-B44_03,HLA-C03_01,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 9 Human HLA-A02_01,HLA-A23_01,HLA-B18_01,HLA-B44_03,HLA-C04_01,HLA-C07_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_08 20 Human HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_09 20 Human HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_10 19 Human HLA-A02_01,HLA-A01_01,HLA-B18_01,HLA-B39_24,HLA-C05_01,HLA-C07_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 20 Human HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_12 3 Human HLA-A02_01,HLA-B13_02,HLA-B41_01,HLA-C06_02,HLA-C17_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_13 3 Human HLA-A02_01,HLA-A11_01,HLA-B27_05,HLA-B56_01,HLA-C01_02,HLA-C02_02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_14 4 Human HLA-A03_01,HLA-A32_01,HLA-B27_05,HLA-B45_01,HLA-C01_02,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_15 9 Human HLA-A01_01,HLA-A32_01,HLA-B08_01,HLA-C07_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_16 3 Human HLA-A11_01,HLA-B14_02,HLA-B44_02,HLA-C05_01,HLA-C08_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_17 3 Human HLA-A11_01,HLA-B18_03,HLA-B35_01,HLA-C04_01,HLA-C07_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_18 3 Human HLA-A03_01,HLA-A24_02,HLA-B07_02,HLA-B27_05
Showing 1 to 6 of 26 entries



Detailed view of sample SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07



IDSampleIDRawFileNameProcessCulture ConditionsDisease StateCommentsMHCClassPubMed IDPeptideIsolation MethodAntibodyMass SpectrometerLC SystemiRT PeptidesAcquisition ModeFragmentation MethodGradientGradient LengthFlow RateReplicate Number
ID
SampleID
RawFileName
Organism
Process
Tissue Type
Cell Type
Culture Conditions
Disease State
Comments
MHCClass
MHCAllele
PubMed ID
Peptide
Isolation Method
Antibody
Mass Spectrometer
LC System
iRT Peptides
Acquisition Mode
Fragmentation Method
Gradient
Gradient Length
Flow Rate
Replicate Number
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_03062014_rep5.raw In vitro suspension EBV transformed class I 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 1
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_03062014_rep6.raw In vitro suspension EBV transformed class I 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 2
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_13052014_rep1.raw In vitro suspension EBV transformed class I 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 3
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_15082014_rep7.raw In vitro suspension EBV transformed class I 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 4
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_13052014_rep2.raw In vitro suspension EBV transformed class I 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 5
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_15082014_rep9_2.raw In vitro suspension EBV transformed class I 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 6
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_16052014_rep4.raw In vitro suspension EBV transformed class I 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 7
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_15082014_rep8.raw In vitro suspension EBV transformed class I 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 8
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 SYSMHC00010_pat_SR_16052014_rep3.raw In vitro suspension EBV transformed class I 26857467 native Mild acid elution Q-Exactive Plus no DDA HCD 3-40% 151 9
Showing 1 to 2 of 9 entries